NCT02304601 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Brünger M, Spyra K
Prevalence of comorbid depressive symptoms in rehabilitation: A cross-indication, nationwide observational study. J Rehabil Med. 2016 Nov 11;48(10):903-908. doi: 10.2340/16501977-2156.
Brünger M, Streibelt M, Schmidt C, Spyra K
[Psychometric Testing of a Generic Assessment Tool for the Identification of Biopsychosocial Impairments in Persons with an Approval for Medical Rehabilitation]. Rehabilitation (Stuttg). 2016 Jun;55(3):175-81. d
Streibelt M, Brünger M
[How many work-related therapeutic services do patients with severe restrictions of work ability receive? Analysis of a representative rehabilitation sample across indications]. Rehabilitation (Stuttg). 2014 Dec;53(6):369-75. German.

Entwicklung Und Testung Eines Generischen Screenings für Die Vorabschätzung Von Fallgruppen im Antragsverfahren

Clinical trial NCT02304601 - References